Výsledky vyhledávání - "L. E. Laplante"

Once- vs. Twice-Daily Nitrendipine in the Treatment of Mild to Moderate Hypertension

Autor: E Z Rabin, Peter Bolli, Mukherjee J, S. P. Handa, J. M. Wright, Strong Ha, Cobby J, L. E. Laplante

Publikováno v: Journal of Cardiovascular Pharmacology. 17:S182-S185

Improved measurement of the plasma concentration of nitrendipine demonstrated a plasma half-life of 17-21 h, allowing once-daily (o.d.) instead of currently twice-daily (b.i.d.) dosing. To determine the effectiveness of nitrendipine given o.d. vs. b.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d800fa60fd4ffa3477b2d2a0d6399522
https://doi.org/10.1097/00005344-199117002-00047

Zobrazit plný text záznamu

Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group

Autor: P, Bolli, J, Cobby, S P, Handa, L E, LaPlante, J, Mukherjee, E Z, Rabin, H A, Strong, J M, Wright

Publikováno v: The Canadian journal of cardiology. 7(2)

Improved measurement of plasma concentrations of nitrendipine demonstrates a plasma half-life of 17 to 21 h allowing once daily dosing for antihypertensive treatment. To determine the effectiveness and tolerability of nitrendipine given once versus t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acd2e382744a60b3bc2c0d7882fdddde
https://pubmed.ncbi.nlm.nih.gov/2049684

Zobrazit plný text záznamu

Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group

Autor: P, Bolli, J, Cobby, S P, Handa, L E, Laplante, J, Mukherjee, E Z, Rabin, H A, Strong, J M, Wright

Publikováno v: Journal of cardiovascular pharmacology. 17

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7bd339324aa29303efda5f70579d4ccd
https://pubmed.ncbi.nlm.nih.gov/1715478

Zobrazit plný text záznamu

A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group

Autor: M G, Baird, M M, Bentley-Taylor, S G, Carruthers, K G, Dawson, L E, Laplante, P, Larochelle, K L, MacCannell, A, Marquez-Julio, L R, Silverberg, P, Talbot

Publikováno v: Clinical and investigative medicine. Medecine clinique et experimentale. 7(2)

The effects of metoprolol (Betaloc tablets) in a group of 193 hypertensives were compared with the effects of a slow-release formulation (Betaloc Durules) in a further group of 196 patients. Patients were selected at random for treatment. There were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1caea5a50ada4d25b2e77a62924e9cf5
https://pubmed.ncbi.nlm.nih.gov/6380858

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání